Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maruzen Pharmaceutical is a leading Japanese manufacturer specializing in the extraction and refinement of active ingredients from natural plant sources. Founded in 1949 and headquartered in Hiroshima, the company is a global authority on licorice-derived compounds, particularly glycyrrhizin, which is used extensively in pharmaceuticals and hepatology. Beyond medicine, Maruzen provides a vast portfolio of botanical extracts for the cosmetics and functional food industries, supported by rigorous scientific research and high-purity extraction technologies. Their business encompasses the entire value chain from raw material procurement to the production of active pharmaceutical ingredients (APIs). The company is recognized for its commitment to validating traditional herbal knowledge through modern pharmacological standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maruzen Pharmaceutical.